You are here

Genentech

FDA Approves Genentech’s Rituxan For Rare Autoimmune Disease Pemphigus Vulgaris

FDA Approves Genentech’s Rituxan For Rare Autoimmune Disease Pemphigus Vulgaris

CP Wire

pemphigus vulgaris

Genentech/Roche

Flag link:

Genentech signs $534M deal with Microbiotica to search gut bacteria for IBD targets, new drugs

Genentech signs $534M deal with Microbiotica to search gut bacteria for IBD targets, new drugs

Fierce Biotech

Flag link:

Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results

Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results

Xconomy

clinical trials

Flag link:

Genentech allies with a metagenomics upstart in New York on a discovery deal jam packed with biobucks

Genentech allies with a metagenomics upstart in New York on a discovery deal jam packed with biobucks

Endpoints

Lodo Therapeutics

Flag link:

FDA promises Roche a snap decision on Tecentriq triple for frontline lung cancer as it falls even further behind Merck, Bristol-Myers

FDA promises Roche a snap decision on Tecentriq triple for frontline lung cancer as it falls even further behind Merck, Bristol-Myers

Endpoints

Flag link:

Genentech antibody spotlights new target for antibiotic-resistant bacteria

Genentech antibody spotlights new target for antibiotic-resistant bacteria

Fierce Biotech

antibiotic resistance

Flag link:

After FDA setback, Bellicum bolsters R&D team with ex-Genentech executive

After FDA setback, Bellicum bolsters R&D team with ex-Genentech executive

Fierce Biotech

Flag link:

[forum discussion]Over 50

[forum discussion]Over 50

Cafepharma Message Boards

Flag link:

Genentech beefs up its PD-L1 combo pipeline, signing the ‘don’t eat me’ specialists at Forty Seven

Genentech beefs up its PD-L1 combo pipeline, signing the ‘don’t eat me’ specialists at Forty Seven

Endpoints

anti-PD-1 immunotherapy

Flag link:

Roche Gains Ground on Rivals With Drug Combo’s Success in Lung Cancer

Roche Gains Ground on Rivals With Drug Combo’s Success in Lung Cancer

Xconomy

Flag link:

FDA Approves Genentech Hemophilia Drug, But Adds Safety Warning

FDA Approves Genentech Hemophilia Drug, But Adds Safety Warning

Xconomy

Flag link:

Genentech inks $650M deal with protein degradation pioneer Arvinas

Genentech inks $650M deal with protein degradation pioneer Arvinas

Endpoints

targeted protein degradation

Flag link:

Last week in pharma.bio.device.lab November 5-11 2017

Last week in pharma.bio.device.lab November 5-11 2017

CP Wire

Valeant Pharmaceuticals

physician payments

Flag link:

Amgen and Genentech are the latest drug makers to lay off workers

Amgen and Genentech are the latest drug makers to lay off workers

Stat

drug manufacturing

Flag link:

[forum discussion]Huge Headcount Reductions

[forum discussion]Huge Headcount Reductions

Cafepharma Message Boards

Flag link:

[forum discussion]Should rank reports be eliminated?

[forum discussion]Should rank reports be eliminated?

Cafepharma Message Boards

multiple sclerosis

Flag link:

New target could yield treatment for Alzheimer's, ALS and more

New target could yield treatment for Alzheimer's, ALS and more

Fierce Biotech

drug development

Alzheimer's disease

Flag link:

Exelixis and Genentech hammer out new deal terms

Exelixis and Genentech hammer out new deal terms

BioPharma Dive

Flag link:

Roche looks into PML report for Ocrevus patient

Roche looks into PML report for Ocrevus patient

BioPharma Dive

multiple sclerosis

Flag link:

Roche unit Genentech takes on Pfizer with new lung cancer data

Roche unit Genentech takes on Pfizer with new lung cancer data

BioPharma Dive

non-small cell lung cancer

Flag link:

Pages